Beate Rau, Charité University of Berlin Campus Virchow-Klinikum, Berlin, DE François Quenet, Centre Régional du Cancer, Montpellier, Montpellier, FR

Size: px
Start display at page:

Download "Beate Rau, Charité University of Berlin Campus Virchow-Klinikum, Berlin, DE François Quenet, Centre Régional du Cancer, Montpellier, Montpellier, FR"

Transcription

1 Chairs Beate Rau, Charité University of Berlin Campus Virchow-Klinikum, Berlin, DE François Quenet, Centre Régional du Cancer, Montpellier, Montpellier, FR Faculty members Frédéric Bibeau, Caen University Hospital, Caen, FR Andreas Brandl, Charité Campus Berlin, Berlin, DE Marcello Deraco, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, IT Roland Francis, Charité Campus Berlin, Berlin, DE Olivier Glehen, Centre Hospitalier Lyon-Sud, Pierre Bénite, Lyon, FR Gabriel Glockzin, Klinikum Bogenhausen, Munich, DE Santiago González-Moreno, Centro Oncológico MD Anderson, Madrid, SP Chirsthardt Köhler, Asklepios Klinik, Hamburg, DE Rea Lo Dico, Lariboisière Hospital, Paris, FR Faheez Mohamed, Basingstoke and North Hampshire Hospital, Basingstoke,UK Markus Möhler, Stéphanie Nougaret, Institut Régional du Cancer de Montpellier, Montpellier, FR Pompiliu Piso, St John and God Hospital, Regensburg, DE Marc Pocard, Lariboisière Hospital, Paris, FR/Paris Diderot 7 University, Paris, FR Emmanuelle Samalin, Institut Régional du Cancer de Montpellier, Montpellier, FR Olivia Sgarbura, Institut Régional du Cancer de Montpellier, Montpellier, FR Marianne Sinn, Charité Campus Berlin, Berlin, DE Paul Sugarbaker, Washington Cancer Center, Washington, US Kurt Van der Speeten, Ziekenhuis Oost-Limburg, Genk, BE Willemien van Driel, Antoni van Leeuwenhoek, Netherlands Cancer Institute, Amsterdam, NL Vic Verwaal, Aarhus University Hospital, DK

2 Programme Thursday 15 th February 13:00 Introduction B. Rau Treatment principles for Peritoneal Surface Malignancies: surgical approach and clinical pathological pathway - Chairs: B. Rau, F. Quenet Techniques of cytoreductive surgery with peritonectomy procedures (CRS) P. Sugarbaker Video technique CRS from Regensburg P. Piso Pharmacology of different techniques of intraperitoneal drug administration; role of heat and carriers K. Van der Speeten The role of laparoscopy in PSM M. Pocard Preoperative staging in peritoneal metastases: necessary and nice to have (morphologic exams and peritoneal carcinomatosis) S. Nougaret Coffee break Perioperative management Chairs: M. Pocard, P. Piso Patient selection for CRS and HIPEC V. Verwaal OR personnel safety related to HIPEC A. Brandl To speak the same language: PCI, CCR and PSS G. Glockzin Perioperative management of CRS and HIPEC: view of the anaesthesiologist R. Francis

3 17: Prevention and management of postoperative surgical complications M. Pocard Overview of international guidelines for CRS and HIPEC S. Santiago González-Moreno How to start a new center for the treatment of PSM M. Pocard Friday 16 th February Hands on session Tutors: M. Deraco, O. Glehen, G. Glockzin, S. González-Moreno, P. Piso, C. Köhler, F. Quenet, O. Sgarbura,Andreas Brandl, M. Pocard, S. Nougaret, R. Lo Dico, B. Rau, P. Sugarbaker, K. Van der Speeten, V. Verwaal,, F. Mohamed 08: Anatomical structure in animal L. K. Groebler Debriefing from human to animal B. Rau Right upper abdomen Right Abdominal wall Interenteric Right Diaphram arcus tendineum Resection gastric surface Bursa omentalis Splenectomy Pancreatic tail resection Coffee Break Left upper abdomen Left abdominal wall Left diaphragm arcus tendineum Resection of serosal surface of bowel mesenterium Hepatoduodenal ligament Cholecystectomy Resection of small bowel Triangle ligament Morrison pouch

4 Lunch Pelvic Resection of omentum Resection of serosal surface of bowel Resection of peritoneal surface of the bladder Lymph node preparation central mesenterical route Devices HIPEC open and Devices HIPEC close Coffee Break Gastric cancer (debate) Chairs V. Verwaal, A. Brandl Prophylactic HIPEC in gastric cancer: pro O. Glehen Prophylactic HIPEC in gastric cancer: contra M. Möhler CRS and HIPEC in peritoneal metastatic gastric cancer: pro B. Rau CRS and HIPEC in peritoneal metastatic gastric cancer: contra M. Möhler Young surgeons video master class Pseudomyxoma Moderator: F. Mohamed Colorectal cancer Moderator: V. Verwaal Gastric cancer Moderator: O. Glehen Ovarian cancer Moderator: C. Köhler Mesothelioma Moderator: M. Deraco

5 Rare cancer sites Moderator: S. González-Moreno Discussion with the experts Saturday 17 th March Frequent indications and systemic treatment: what is new Update Chairs: M. Deraco, S. González-Moreno Pseudomyxoma Peritonei F. Mohamed Malignant Peritoneal Mesothelioma and Primay Peritoneal Carcinoma M. Deraco Peritoneal Metastases from Ovarian Cancer W. J. van Driel Discussion with the experts Chairs: K. Van der Speeten, M. Pocard CRS and HIPEC video M. Deraco Ovarectomy per principle? C. Köhler Splenectomy per principle? A. Brandl Critical technical points in upper abdomen O. Sgarbura Coffee Break Peritoneal metastases from colorectal cancer: debate Chairs: I. de Hingh, F. Mohamed CRS on patients with extra peritoneal metastases in CRC: pro R. Lo Dico

6 CRS on patients with extra peritoneal metastases in CRC: contra E. Samalin Treatment options in in peritoneal metastases from colorectal origin: the medical oncology point of view M. Sinn Peritoneal Metastases from Colorectal Cancer (particularities of CRS, HIPEC and CCR score) results of the trial F. Quenet Importance of pathologic response F. Bibeau What is new about PIPAC in gastric and colorectal cancer O.Sgabura Conclusions

Beate Rau, Campus Virchow-Klinikum, Berlin, DE François Quenet, Centre Régional du Cancer, Montpellier, Montpellier, FR

Beate Rau, Campus Virchow-Klinikum, Berlin, DE François Quenet, Centre Régional du Cancer, Montpellier, Montpellier, FR Chairs Beate Rau, Campus Virchow-Klinikum, Berlin, DE François Quenet, Centre Régional du Cancer, Montpellier, Montpellier, FR Faculty members Salah-Eddin Al-Batran, Institut für Klinisch-Onchologische

More information

Beate Rau, Charité Campus Berlin, Berlin, DE Tom Cecil, Basingstoke and North Hampshire Hospital, Basingstoke, UK

Beate Rau, Charité Campus Berlin, Berlin, DE Tom Cecil, Basingstoke and North Hampshire Hospital, Basingstoke, UK Chairs Beate Rau, Charité Campus Berlin, Berlin, DE Tom Cecil, Basingstoke and North Hampshire Hospital, Basingstoke, UK Faculty members Andreas Brandl, Charité Campus Berlin, Berlin, DE James Coakes,

More information

Management of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) after Cytoreductive Surgery (CRS)

Management of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) after Cytoreductive Surgery (CRS) Management of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) after Cytoreductive Surgery (CRS) 19-21 MARCH 2015 HAMBURG EUROPEAN SCHOOL OF PERITONEAL SURFACE ONCOLOGY Management of Hyperthermic Intraperitoneal

More information

PRELIMINARY PROGRAM. 11 th International Workshop on Peritoneal Surface Malignancy SEPTEMBER 9-11,

PRELIMINARY PROGRAM. 11 th International Workshop on Peritoneal Surface Malignancy SEPTEMBER 9-11, 11 th International Workshop on Peritoneal Surface Malignancy PRELIMINARY PROGRAM SEPTEMBER 9-11, 2018 Maison de la Chimie, Paris, France www.psogi2018.com 9THSATURDAY 8TH 2SUNDAY Saturday, September 8

More information

International scientific-practical conference «Management of Peritoneal Surfaces Malignancy» Irkutsk, August 9-11, Program

International scientific-practical conference «Management of Peritoneal Surfaces Malignancy» Irkutsk, August 9-11, Program Day 1 Program Wednesday, 9 of August, 2017 Regional Oncology Center, Irkutsk Conference Hall 8.00-8.30 Registration of participants 8.30-8.50 Opening conference Welcome Gouverneur (Sergey Levchenko) Welcome

More information

Results of CRS and HIPEC in. Colorectal PSM. and. Pseudomyxoma Peritonei

Results of CRS and HIPEC in. Colorectal PSM. and. Pseudomyxoma Peritonei Results of CRS and HIPEC in Colorectal PSM and Pseudomyxoma Peritonei K. Van der Speeten 05/10/12 Introduction Results Morbidity & Mortality Adjuvant HIPEC Conclusions K. Van der Speeten Introduction PSM

More information

FINAL SCIENTIFIC PROGRAMME

FINAL SCIENTIFIC PROGRAMME FINAL SCIENTIFIC PROGRAMME AGENDA Day 1 Speaker Chairpersons 8:30 AM 8:45 AM 8:45 AM 9:00 AM Intraperitoneal chemotherapytypes, techniques, tips Choice of drugs and carrier solutions for intraperitoneal

More information

Patient Presentation. 32 y.o. female complains of lower abdominal mass CEA = 433, CA125 = 201

Patient Presentation. 32 y.o. female complains of lower abdominal mass CEA = 433, CA125 = 201 Patient Presentation 32 y.o. female complains of lower abdominal mass CEA = 433, CA125 = 201 CT shows: Thickening of the right hemidiaphragm CT shows: Fluid in the right paracolic sulcus CT shows: Large

More information

CURRICULUM VITAE 2005

CURRICULUM VITAE 2005 CURRICULUM VITAE 2005 Last Name : GLEHEN Fist Name: Olivier Current Address Department of Surgical Oncology University Hospital of LYON-SUD 69695 Pierre Bénite, France e-mail : olivier.glehen@chu-lyon.fr

More information

Regional Therapy for Management of Peritoneal Carcinomatosis from Gastrointestinal Malignancies

Regional Therapy for Management of Peritoneal Carcinomatosis from Gastrointestinal Malignancies Regional Therapy for Management of Peritoneal Carcinomatosis from Gastrointestinal Malignancies Byrne Lee, MD FACS Chief, Mixed Tumor Surgery Service City of Hope Division of Surgical Oncology September

More information

Regional Therapy for Management of Peritoneal Carcinomatosis from Gastrointestinal Malignancies

Regional Therapy for Management of Peritoneal Carcinomatosis from Gastrointestinal Malignancies Regional Therapy for Management of Peritoneal Carcinomatosis from Gastrointestinal Malignancies Byrne Lee, MD FACS Chief, Mixed Tumor Surgery Service City of Hope Division of Surgical Oncology September

More information

10 th International Congress on Peritoneal Surface Malignancies

10 th International Congress on Peritoneal Surface Malignancies 10 th International Congress on Peritoneal Surface Malignancies November 17 19, 2016 Omni Shoreham Hotel Washington, DC Course Director: MedStar Washington Hospital Center Washington, DC www.psogi2016.com

More information

Cytoreductive surgery and perioperative intraperitoneal chemotherapy for Rare Peritoneal Disease. Results of the French multicentric database

Cytoreductive surgery and perioperative intraperitoneal chemotherapy for Rare Peritoneal Disease. Results of the French multicentric database Cytoreductive surgery and perioperative intraperitoneal chemotherapy for Rare Peritoneal Disease Results of the French multicentric database Université Lyon 1 Centre Hospitalo-Universitaire Lyon-Sud EA

More information

Pre-operative assessment of patients for cytoreduction and HIPEC

Pre-operative assessment of patients for cytoreduction and HIPEC Pre-operative assessment of patients for cytoreduction and HIPEC Washington Hospital Center Washington, DC, USA Ovarian Cancer Surgery New Strategies Bergamo, Italy May 5, 2011 Background Cytoreductive

More information

Colorectal peritoneal metastases and IMPACT

Colorectal peritoneal metastases and IMPACT Colorectal peritoneal metastases and IMPACT Vicki Pleavin-Evans Peritoneal Malignancy Clinical Nurse Specialist PMI Basingstoke Basingstoke and North Hampshire Hospital Aldermaston Road, Basingstoke, Hampshire

More information

Pseudomyxoma peritoni et al HOW TO TREAT PERITONEAL MALIGNANCIES

Pseudomyxoma peritoni et al HOW TO TREAT PERITONEAL MALIGNANCIES Pseudomyxoma peritoni et al HOW TO TREAT PERITONEAL MALIGNANCIES Case Presentation 72M 3 weeks abdominal distension and lower abdominal pain. 3 weeks constipation w/ 2-3 BM per week. Post-prandial epigastric/substernal

More information

INTRAPERITONEAL CHEMOTHERAPY, CYTOREDUCTION

INTRAPERITONEAL CHEMOTHERAPY, CYTOREDUCTION INTRAPERITONEAL CHEMOTHERAPY, CYTOREDUCTION Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures,

More information

Results of a French Multicentric Analysis

Results of a French Multicentric Analysis Peritonectomy, Perioperative and Intraoperative Intraperitoneal Chemotherapy for Carcinosis Arising from Gastric Cancer Results of a French Multicentric Analysis 17 th -19 th 2008 Report Digestive and

More information

Management of Pseudomyxoma Peritonei (PMP) and Colon Cancer Carcinomatosis by Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).

Management of Pseudomyxoma Peritonei (PMP) and Colon Cancer Carcinomatosis by Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (HIPEC). Surgical Oncology Department Management of Pseudomyxoma Peritonei (PMP) and Colon Cancer Carcinomatosis by Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (HIPEC). 21/04/2010 THERMOMETRY 1000-1500

More information

Department of Surgery, Kusatsu General Hospital, Yabase Kusatsu 1660, Japan 2

Department of Surgery, Kusatsu General Hospital, Yabase Kusatsu 1660, Japan 2 Gastroenterology Research and Practice Volume 2012, Article ID 836425, 5 pages doi:10.1155/2012/836425 Clinical Study Morbidity and Mortality Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal

More information

Hepatobiliary Procedures in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

Hepatobiliary Procedures in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Ann Surg Oncol (2011) 18:1052 1059 DOI 10.1245/s10434-010-1415-3 ORIGINAL ARTICLE GASTROINTESTINAL ONCOLOGY Hepatobiliary Procedures in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal

More information

CRS e HIPEC: Efficacia e Limiti

CRS e HIPEC: Efficacia e Limiti CRS e HIPEC: Efficacia e Limiti Marcello Deraco M.D. Responsabile Tumori Peritoneali The Concept of Cytoreductive Surgery Means a complete removal of all macroscopic tumor in the peritoneal cavity; It

More information

HIPEC Controversies in the Indications and Application of Regional Chemotherapy for Peritoneal Surface Malignancies

HIPEC Controversies in the Indications and Application of Regional Chemotherapy for Peritoneal Surface Malignancies HIPEC Controversies in the Indications and Application of Regional Chemotherapy for Peritoneal Surface Malignancies Crescent City Cancer Update: GI and HPB Saturday September 24, 2016 George M. Fuhrman,

More information

TREATMENT OF PERITONEAL COLORECTAL CARCINOMATOSIS

TREATMENT OF PERITONEAL COLORECTAL CARCINOMATOSIS TREATMENT OF PERITONEAL COLORECTAL CARCINOMATOSIS Anna Lepistö, MD, PhD Department of Colorectal Surgery, Abdominal Center, Helsinki University Hospital Incidence, prevalence and risk factors for peritoneal

More information

HIPEC AND COMPLICATED COLORECTAL SURGERY

HIPEC AND COMPLICATED COLORECTAL SURGERY HIPEC AND COMPLICATED COLORECTAL SURGERY START: May 16th, 2014 END: May 17th, 2014 LOCATION: Vilnius, Lithuania OFFICIAL LANGUAGE: English Translation services will not be provided CERTIFICATION: Vilnius

More information

Peritoneal dissemination is a common manifestation of disease

Peritoneal dissemination is a common manifestation of disease ORIGINAL ARTICLE Identification of a Subgroup of Patients at Highest Risk for Complications After Surgical Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Dario Baratti, MD, Shigeki Kusamura,

More information

NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE

NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE INTERVENTIONAL PROCEDURES PROGRAMME Interventional procedures overview of complete cytoreduction Introduction (Sugarbaker technique) for pseudomyxoma peritonei

More information

ORIGINAL ARTICLE GASTROINTESTINAL ONCOLOGY. Ann Surg Oncol (2018) 25:

ORIGINAL ARTICLE GASTROINTESTINAL ONCOLOGY. Ann Surg Oncol (2018) 25: Ann Surg Oncol (2018) 25:1184 1192 https://doi.org/10.1245/s10434-018-6369-x ORIGINAL ARTICLE GASTROINTESTINAL ONCOLOGY Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Peritoneal

More information

Wojciech Nowak, Rector of the Jagiellonian University Medical College, Kraków (PL)

Wojciech Nowak, Rector of the Jagiellonian University Medical College, Kraków (PL) Chairs Jakub Kenig, Jagiellonian University Medical College, Kraków (PL) Riccardo A. Audisio, Whiston Hospital, University of Liverpool, Liverpool, (UK) Tomasz Grodzicki, Jagiellonian University Medical

More information

Clinical Policy: Intraperitoneal Hyperthermic Chemotherapy for Abdominopelvic Cancers Reference Number: CP.MP. 346

Clinical Policy: Intraperitoneal Hyperthermic Chemotherapy for Abdominopelvic Cancers Reference Number: CP.MP. 346 Clinical Policy: Intraperitoneal Hyperthermic Chemotherapy for Abdominopelvic Reference Number: CP.MP. 346 Effective Date: 11/15 Last Review Date: 11/17 See Important Reminder at the end of this policy

More information

Cytoreduction and HIPEC in The Netherlands: Nationwide Long-term Outcome Following the Dutch Protocol

Cytoreduction and HIPEC in The Netherlands: Nationwide Long-term Outcome Following the Dutch Protocol Ann Surg Oncol (2013) 20:4224 4230 DOI 10.1245/s10434-013-3145-9 ORIGINAL ARTICLE GASTROINTESTINAL ONCOLOGY Cytoreduction and HIPEC in The Netherlands: Nationwide Long-term Outcome Following the Dutch

More information

Planned relaparotomy following curative resection of a locally advanced gastrointestinal cancer

Planned relaparotomy following curative resection of a locally advanced gastrointestinal cancer Planned relaparotomy following curative resection of a locally advanced gastrointestinal cancer PD Dr. med. Michel Adamina, MSc Department of Surgery Agenda Prerequisite for successful CRS HIPEC Planned

More information

Surgical Department, Didimotichon General Hospital, Didimotichon, Greece 2

Surgical Department, Didimotichon General Hospital, Didimotichon, Greece 2 Hindawi Publishing Corporation Journal of Oncology Volume 22, Article ID 35834, 6 pages doi:.55/22/35834 Clinical Study Cytoreductive Surgery Combined with Hyperthermic Intraperitoneal Intraoperative Chemotherapy

More information

Contents. Part 1. Peritoneal Carcinomatosis: Basic Concepts

Contents. Part 1. Peritoneal Carcinomatosis: Basic Concepts Contents Part 1. Peritoneal Carcinomatosis: Basic Concepts 1. Structure and Function of Mesothelial Cells... 1 Introduction... 1 Structure of Mesothelial Cells... 1 Mesothelial Cell Functions... 3 Slippery

More information

Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Medical Coverage Policy Effective Date...10/15/2017 Next Review Date...10/15/2018 Coverage Policy Number... 0396 Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Table of Contents Related Coverage Resources

More information

Specialised Services Policy: CP02 Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Cytoreductive Surgery for treatment of Pseudomyxoma Peritonei

Specialised Services Policy: CP02 Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Cytoreductive Surgery for treatment of Pseudomyxoma Peritonei Specialised Services Policy: CP02 Hyperthermic Intraperitoneal Chemotherapy (HIPEC) of Pseudomyxoma Peritonei Document Author: Assistant Medical Director Executive Lead: Medical Director Approved by: Management

More information

INTRAOPERATIVE HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (HIPEC)

INTRAOPERATIVE HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (HIPEC) UnitedHealthcare Commercial Medical Policy INTRAOPERATIVE HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (HIPEC) Policy Number: SUR052 Effective Date: January 1, 2019 Table of Contents Page INSTRUCTIONS FOR

More information

Cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei

Cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei Int J Colorectal Dis (2005) 20:155 160 DOI 10.1007/s00384-004-0648-7 O R I G I N A L A R T I C L E Z. Güner U. Schmidt M. H. Dahlke H. J. Schlitt J. Klempnauer P. Piso Cytoreductive surgery and intraperitoneal

More information

Surgical Oncology, Mercy Medical Center, Baltimore, MD

Surgical Oncology, Mercy Medical Center, Baltimore, MD Ann Surg Oncol (2012) 19:110 114 DOI 10.1245/s10434-011-1840-y ORIGINAL ARTICLE GASTROINTESTINAL ONCOLOGY The Role of Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy (CRS/HIPEC) in Patients

More information

Gastrointestinal Oncology

Gastrointestinal Oncology 2 nd MD ANDERSON INTERNATIONAL MEETING IN Gastrointestinal Oncology CURRENT PRACTICE AND CONTROVERSIES in the Era of Personalized Medicine e Madrid, 13 th -15 th November, 2019 SCIENTIFIC PROGRAM Meeting

More information

POLICIES AND PROCEDURE MANUAL

POLICIES AND PROCEDURE MANUAL POLICIES AND PROCEDURE MANUAL Policy: MP278 Section: Medical Benefit Policy Subject: Hyperthermia in Cancer Therapy (e.g., HIPEC) I. Policy: Hyperthermia in Cancer Therapy (e.g., HIPEC) II. Purpose/Objective:

More information

CRS and HIPEC for Colorectal Cancer. Rajesh Nair, MD UF Health Cancer Center-Orlando Health March 11, 2017

CRS and HIPEC for Colorectal Cancer. Rajesh Nair, MD UF Health Cancer Center-Orlando Health March 11, 2017 CRS and HIPEC for Colorectal Cancer Rajesh Nair, MD UF Health Cancer Center-Orlando Health March 11, 2017 Peritoneal Carcinomatosis from CRC Historically, a devastating problem Extreme morbidity from disease

More information

Clinical Study Laparoscopic Cytoreductive Surgery and HIPEC in Patients with Limited Pseudomyxoma Peritonei of Appendiceal Origin

Clinical Study Laparoscopic Cytoreductive Surgery and HIPEC in Patients with Limited Pseudomyxoma Peritonei of Appendiceal Origin Gastroenterology Research and Practice Volume 2012, Article ID 981245, 5 pages doi:10.1155/2012/981245 Clinical Study Laparoscopic Cytoreductive Surgery and HIPEC in Patients with Limited Pseudomyxoma

More information

Peritonectomy plus hyperthermic peritoneal perfusion for the treatment of peritoneal carcinosis H. Müller, MD, FACS

Peritonectomy plus hyperthermic peritoneal perfusion for the treatment of peritoneal carcinosis H. Müller, MD, FACS Peritonectomy plus hyperthermic peritoneal perfusion for the treatment of peritoneal carcinosis H. Müller, MD, FACS Department of surgical oncology, Carl von Hess hospital, Hammelburg, Germany www.klinik-hammelburg.de

More information

1. Introduction. Correspondence should be addressed to Horacio N. López-Basave, Received 23 May 2011; Accepted 20 June 2011

1. Introduction. Correspondence should be addressed to Horacio N. López-Basave, Received 23 May 2011; Accepted 20 June 2011 International Scholarly Research Network ISRN Oncology Volume 2011, Article ID 526384, 6 pages doi:10.5402/2011/526384 Research Article Morbidity and Mortality of Cytoreductive Surgery with Hyperthermic

More information

Correspondence should be addressed to David Morris; Received 17 February 2013; Revised 14 April 2013; Accepted 24 June 2013

Correspondence should be addressed to David Morris; Received 17 February 2013; Revised 14 April 2013; Accepted 24 June 2013 International Surgical Oncology Volume 2013, Article ID 461041, 5 pages http://dx.doi.org/10.1155/2013/461041 Research Article Quality of Life Study following Cytoreductive Surgery and Intraperitoneal

More information

Rationale for the treatment. Peritoneal Surface Malignancy

Rationale for the treatment. Peritoneal Surface Malignancy Rationale for the treatment of Peritoneal Surface Malignancy K. Van der Speeten 05/10/12 A full circle :acknowledgements Rationale for the treatment of Peritoneal Surface Malignancy K. Van der Speeten

More information

Welcome Address. Symposium Chairmen. Dear friends and colleagues,

Welcome Address. Symposium Chairmen. Dear friends and colleagues, Welcome Address Dear friends and colleagues, It is a great pleasure for us to announce the organization of the PSOGI International Symposium on Advanced Ovarian Cancer which will be held in Athens, Greece

More information

ESSO Advanced Course on UPPER GI Malignancy

ESSO Advanced Course on UPPER GI Malignancy ESSO Advanced Course on UPPER GI Malignancy In association with PSSO (Polish Society of Surgical Oncology) 18-19 October 2013 POZNÁN ESSO Advanced Course on Upper Gi Malignancy Course directors Chair:

More information

Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis

Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis Vassos et al. World Journal of Surgical Oncology (2016) 14:42 DOI 10.1186/s12957-016-0804-x RESEARCH Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal (HIPEC) in patients with recurrent

More information

U T C H. No disclosure

U T C H. No disclosure D U GOG T C H Randomized phase 3 trial comparing primary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for stage III epithelial ovarian cancer: OVHIPEC-2 Willemien van

More information

ESSO Advanced Course on Primary Liver Tumours

ESSO Advanced Course on Primary Liver Tumours ESSO Advanced Course on Primary Liver Tumours 24-25 April 2014 LIVERPOOL (UK) Endorsed by ESSO Advanced Course on Primary Liver Tumours Chair Hassan Malik, University Hospital Aintree NHS Trust, Liverpool,

More information

MP Hyperthermic Intraperitoneal Chemotherapy for Select IntraAbdominal and Pelvic Malignancies. Related Policies None

MP Hyperthermic Intraperitoneal Chemotherapy for Select IntraAbdominal and Pelvic Malignancies. Related Policies None Medical Policy MP 2.03.07 BCBSA Ref. Policy: 2.03.07 Last Review: 10/18/2018 Effective Date: 01/25/2019 Section: Medicine Related Policies None DISCLAIMER Our medical policies are designed for informational

More information

J Clin Oncol 28: by American Society of Clinical Oncology INTRODUCTION

J Clin Oncol 28: by American Society of Clinical Oncology INTRODUCTION VOLUME 28 NUMBER 1 JANUARY 1 2010 JOURNAL OF CLINICAL ONCOLOGY O R I G I N A L R E P O R T Peritoneal Colorectal Carcinomatosis Treated With Surgery and Perioperative Intraperitoneal Chemotherapy: Retrospective

More information

tumor. CRS? HIPEC was well tolerated in our selected patients with PC, some of whom had improved survival.

tumor. CRS? HIPEC was well tolerated in our selected patients with PC, some of whom had improved survival. Ann Surg Oncol (29) 16:345 351 DOI 1.45/s1434-8-226-2 ORIGINAL ARTICLE GASTROINTESTINAL ONCOLOGY Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy Improves Survival in Selected Patients

More information

J Clin Oncol 22: by American Society of Clinical Oncology INTRODUCTION

J Clin Oncol 22: by American Society of Clinical Oncology INTRODUCTION VOLUME 22 NUMBER 16 AUGUST 15 2004 JOURNAL OF CLINICAL ONCOLOGY O R I G I N A L R E P O R T Cytoreductive Surgery Combined With Perioperative Intraperitoneal Chemotherapy for the Management of Peritoneal

More information

is time consuming and expensive. An intra-operative assessment is not going to be helpful if there is no more tissue that can be taken to improve the

is time consuming and expensive. An intra-operative assessment is not going to be helpful if there is no more tissue that can be taken to improve the My name is Barry Feig. I am a Professor of Surgical Oncology at The University of Texas MD Anderson Cancer Center in Houston, Texas. I am going to talk to you today about the role for surgery in the treatment

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Hyperthermic Intraperitoneal Chemotherapy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: hyperthermic_intraperitoneal_chemotherapy 5/19/2005 3/2018 3/2019

More information

Medical Policy An Independent Licensee of the Blue Cross and Blue Shield Association

Medical Policy An Independent Licensee of the Blue Cross and Blue Shield Association Cytoreduction and Hyperthermic Page 1 of 10 Medical Policy An Independent Licensee of the Blue Cross and Blue Shield Association Title: Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for the

More information

Qué operar y que no operar en carcinomatosis peritoneal. Indicaciones y límites.

Qué operar y que no operar en carcinomatosis peritoneal. Indicaciones y límites. Qué operar y que no operar en carcinomatosis peritoneal. Indicaciones y límites. Dr. Pere Bretcha Boix Plataforma de Oncología Hospital quironsalud Torrevieja 1 20-year survival of 70% 2 Appendiceal Neoplasms

More information

ESSO-EYSAC Course on Colorectal Cancer Surgery

ESSO-EYSAC Course on Colorectal Cancer Surgery ESSO-EYSAC Course on Colorectal Cancer Surgery 21-23 January 2016 LJUBLJANA (SI) Young Surgeons & Alumni Club ESSO-EYSAC Course on Colorectal Cancer Surgery Chairs Ibrahim Edhemovic, Institute of Oncology

More information

IJC International Journal of Cancer

IJC International Journal of Cancer IJC International Journal of Cancer Peritoneal carcinomatosis of gastric origin: A population-based study on incidence, survival and risk factors Irene Thomassen 1,2, Yvette R. van Gestel 2, Bert van Ramshorst

More information

Update on the management of malignant peritoneal mesothelioma

Update on the management of malignant peritoneal mesothelioma Review Article Update on the management of malignant peritoneal mesothelioma Paul H. Sugarbaker Center for Gastrointestinal Malignancies, MedStar Washington Hospital Center, Washington, DC, USA Correspondence

More information

Heated Intraperitoneal Chemotherapy (HIPEC) for Advanced Abdominal Cancers

Heated Intraperitoneal Chemotherapy (HIPEC) for Advanced Abdominal Cancers Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/medical-breakthroughs-from-penn-medicine/heated-intraperitonealchemotherapy-hipec-for-advanced-abdominal-cancers/7091/

More information

PROGRAM. 13 th ICRCC Congress on Colorectal Cancer Final Programm Friday, 28 September 2018

PROGRAM. 13 th ICRCC Congress on Colorectal Cancer Final Programm Friday, 28 September 2018 13 th ICRCC Congress on Colorectal Cancer 2018 Final Programm Friday, 28 September 2018 07:30 08:00 Registration 08:00 08:15 Opening Ceremony Prof. K.H. Link, em. Director of Surgical Center Asklepios,

More information

Impact of surgical volume of centers on post-operative outcomes from cytoreductive surgery and hyperthermic intra-peritoneal chemoperfusion

Impact of surgical volume of centers on post-operative outcomes from cytoreductive surgery and hyperthermic intra-peritoneal chemoperfusion Review Article Impact of surgical volume of centers on post-operative outcomes from cytoreductive surgery and hyperthermic intra-peritoneal chemoperfusion Rahul Rajeev, Brittany Klooster, Kiran K. Turaga

More information

Abstract. Materials and methods

Abstract. Materials and methods Int J Gynecol Cancer 2006, 16, 490 495 Long-term survival in advanced ovarian carcinoma following cytoreductive surgery with standard peritonectomy procedures A.-A.K. TENTES, C.G. MIRELIS, S.K. MARKAKIDIS,

More information

Ovarian Tumors. Andrea Hayes-Jordan MD FACS, FAAP Section Chief, Pediatric Surgery/Surgical Onc. UT MD Anderson Cancer Center

Ovarian Tumors. Andrea Hayes-Jordan MD FACS, FAAP Section Chief, Pediatric Surgery/Surgical Onc. UT MD Anderson Cancer Center Ovarian Tumors Andrea Hayes-Jordan MD FACS, FAAP Section Chief, Pediatric Surgery/Surgical Onc. UT MD Anderson Cancer Center Case 13yo female with abdominal pain Ultrasound shows huge ovarian mass Surgeon

More information

Surgical management and neoadjuvant chemotherapy for stage III-IV ovarian cancer

Surgical management and neoadjuvant chemotherapy for stage III-IV ovarian cancer Ovarian cancer Surgical management and neoadjuvant chemotherapy for stage III-IV ovarian cancer JM. Classe, R. Rouzier, O.Glehen, P.Meeus, L.Gladieff, JM. Bereder, F Lécuru Suitable candidates for neo-adjuvant

More information

6 TH ESO-SIOP EUROPE MASTERCLASS IN PAEDIATRIC ONCOLOGY June 2016 Berlin, Germany. Chairs: A. Eggert, DE B. Morland, UK R.

6 TH ESO-SIOP EUROPE MASTERCLASS IN PAEDIATRIC ONCOLOGY June 2016 Berlin, Germany. Chairs: A. Eggert, DE B. Morland, UK R. MASTERCLASS 6 TH ESO-SIOP EUROPE MASTERCLASS IN PAEDIATRIC ONCOLOGY Held with the support of 11-16 June 2016 Berlin, Germany Chairs: A. Eggert, DE B. Morland, UK R. Riccardi, IT INTRODUCTION ESO and SIOP-Europe

More information

Never mistake knowledge for wisdom. One helps you make a living; the other helps you make a life.

Never mistake knowledge for wisdom. One helps you make a living; the other helps you make a life. Never mistake knowledge for wisdom. One helps you make a living; the other helps you make a life. -Sandra Carey In honour of God and to my loving wife, Helena, and our children List of Papers This thesis

More information

GALEN ADVANCED Course

GALEN ADVANCED Course YEAR OF ESOR YEAR OF ESOR GALEN ADVANCED Course Education in partnership Course information This course is aimed at senior residents, board-certified radiologists and fellows interested in abdominal imaging.

More information

Kathleen A. Cummins 1, Gregory B. Russell 2, Konstantinos I. Votanopoulos 1, Perry Shen 1, John H. Stewart 1, Edward A. Levine 1.

Kathleen A. Cummins 1, Gregory B. Russell 2, Konstantinos I. Votanopoulos 1, Perry Shen 1, John H. Stewart 1, Edward A. Levine 1. Original Article Peritoneal dissemination from high-grade appendiceal cancer treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) Kathleen A. Cummins 1, Gregory

More information

MP Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Select Intra-Abdominal and Pelvic Malignancies

MP Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Select Intra-Abdominal and Pelvic Malignancies Medical Policy MP 2.03.07 Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Select Intra-Abdominal and Pelvic BCBSA Ref. Policy: 2.03.07 Last Review: 07/25/2018 Effective Date: 07/25/2018

More information

Vic J. Verwaal, MD, PhD, 1 Sjoerd Bruin, MD, 1 Henk Boot, MD, PhD, 2 Gooike van Slooten, MD, 1 and Harm van Tinteren, ScM 3

Vic J. Verwaal, MD, PhD, 1 Sjoerd Bruin, MD, 1 Henk Boot, MD, PhD, 2 Gooike van Slooten, MD, 1 and Harm van Tinteren, ScM 3 Annals of Surgical Oncology 15(9):2426 2432 DOI: 10.1245/s10434-008-9966-2 8-Year Follow-up of Randomized Trial: Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy

More information

This is a submitted version of a paper published in European Journal of Surgical Oncology. Access to the published version may require subscription.

This is a submitted version of a paper published in European Journal of Surgical Oncology. Access to the published version may require subscription. Uppsala University This is a submitted version of a paper published in European Journal of Surgical Oncology. Citation for the published paper: Cashin, P., Graf, W., Nygren, P., Mahteme, H. (2012) "Cytoreductive

More information

Key words: appendiceal carcinoma; peritonectomy; intraperitoneal chemotherapy.

Key words: appendiceal carcinoma; peritonectomy; intraperitoneal chemotherapy. EJSO 2001; 27: 286 290 doi:10.1053/ejso.2000.1095, available online at http://www.idealibrary.com on Improved prognosis following peritonectomy procedures and hyperthermic intraperitoneal chemotherapy

More information

Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Select Intra-Abdominal and Pelvic Malignancies

Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Select Intra-Abdominal and Pelvic Malignancies Last Review Status/Date: December 2016 Page: 1 of 29 Intraperitoneal Chemotherapy for Select Intra- Description Cytoreductive surgery (CRS) comprises peritonectomy (ie, peritoneal stripping) procedures

More information

Hepatobiliary and pancreatic procedures during cytoreductive surgery and HIPEC

Hepatobiliary and pancreatic procedures during cytoreductive surgery and HIPEC JBUON 2017; 22(5): 1338-1344 ISSN: 1107-0625, online ISSN: 2241-6293 www.jbuon.com E-mail: editorial_office@jbuon.com ORIGINAL ARTICLE Hepatobiliary and pancreatic procedures during cytoreductive surgery

More information

Available online at EJSO 37 (2011) 148e154. Accepted 26 October 2010 Available online 18 November 2010

Available online at   EJSO 37 (2011) 148e154. Accepted 26 October 2010 Available online 18 November 2010 Available online at www.sciencedirect.com EJSO 37 (2011) 148e154 www.ejso.com Prognostic factors and oncologic outcome in 146 patients with colorectal peritoneal carcinomatosis treated with cytoreductive

More information

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Medical Policy An independent licensee of the Blue Cross Blue Shield Association Cytoreductive Surgery and Perioperative Intraperitoneal Page 1 of 26 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Cytoreductive Surgery and Perioperative Intraperitoneal

More information

Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Select Intra-Abdominal and Pelvic Malignancies

Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Select Intra-Abdominal and Pelvic Malignancies Last Review Status/Date: March 2015 Page: 1 of 32 Intraperitoneal Chemotherapy for Select Intra- Description Pseudomyxoma peritonei describes extensive mucus accumulation within the peritoneum resulting

More information

How to deal with patients with isolated peritoneal metastases

How to deal with patients with isolated peritoneal metastases ESMO Preceptorship Programme Colorectal Valencia 18-19 May 2018 Michel DUCREUX, MD, PhD Gustave Roussy Cancer Centre, Grand Paris, FRANCE How to deal with patients with isolated peritoneal metastases DISCLOSURE

More information

Enhanced Recovery after Surgery: Benefits, Challenges and Solutions for Implementation

Enhanced Recovery after Surgery: Benefits, Challenges and Solutions for Implementation Enhanced Recovery after Surgery: Benefits, Challenges and Solutions for Implementation 06-07 November 2015 MILAN (IT) IN PARTNERSHIP WITH Enhanced Recovery after Surgery: Benefits, Challenges and Solutions

More information

Saturday, 13 February 2016

Saturday, 13 February 2016 Saturday, 13 February 2016 16.10 16.15 Opening and welcome C.R. Chapple, Sheffield (GB) 16.15 18.00 What is new in urology 1 Chairs: C. R. Chapple, Sheffield (GB) 16.15 16.35 Functional urology C. Gratzke,

More information

Management of Stage IV Colorectal Cancer: Expanding the Horizon

Management of Stage IV Colorectal Cancer: Expanding the Horizon Management of Stage IV Colorectal Cancer: Expanding the Horizon May Tee, MD, MPH and Jan Franko, MD, PhD MercyOne Surgical Group (Mercy Surgical Affiliates) GI Oncology Conference 2019 March 1, 2019 Disclosures

More information

COLON CANCER PERITONEAL CARCINOMATOSIS TREATMENT Prof. Annibale Donini

COLON CANCER PERITONEAL CARCINOMATOSIS TREATMENT Prof. Annibale Donini UNIVERSITY OF PERUGIA Department of General and Emergency Surgery Chief: Prof. Annibale Donini COLON CANCER PERITONEAL CARCINOMATOSIS TREATMENT Prof. Annibale Donini COLON CANCER IS A HIGHLY FREQUENT NEOPLASIA

More information

SIOP. 7 TH ESO-SIOP EUROPE MASTERCLASS IN PaEDiatRic OncOlOGy June 2018 nauen Ot Groß Behnitz (Berlin area), Germany.

SIOP. 7 TH ESO-SIOP EUROPE MASTERCLASS IN PaEDiatRic OncOlOGy June 2018 nauen Ot Groß Behnitz (Berlin area), Germany. SIOP SIOP Europe the European Society for Paediatric Oncology 7 TH ESO-SIOP EUROPE MASTERCLASS IN PaEDiatRic OncOlOGy 16-21 June 2018 nauen Ot Groß Behnitz (Berlin area), Germany Chairs: S. Bielack, DE

More information

Ascites and malnutrition are predictive factors for incomplete cytoreductive surgery for peritoneal carcinomatosis from gastric cancer

Ascites and malnutrition are predictive factors for incomplete cytoreductive surgery for peritoneal carcinomatosis from gastric cancer The American Journal of Surgery (2013) 205, 668-673 Clinical Surgery Ascites and malnutrition are predictive factors for incomplete cytoreductive surgery for peritoneal carcinomatosis from gastric cancer

More information

Hyperthermic Intraperitoneal Chemotherapy

Hyperthermic Intraperitoneal Chemotherapy Hyperthermic Intraperitoneal Chemotherapy Acta chir belg, 2006, 106, 276-282 Surgery for Peritoneal Carcinomatosis from Colorectal Origin : Techniques and Limitations W. P. Ceelen Surgical Oncology, University

More information

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal and appendiceal carcinomas with peritoneal carcinomatosis

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal and appendiceal carcinomas with peritoneal carcinomatosis JBUON 2017; 22(6): 1547-1553 ISSN: 1107-0625, online ISSN: 2241-6293 www.jbuon.com E-mail: editorial_office@jbuon.com ORIGINAL ARTICLE Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

More information

Computerized System for Staging Peritoneal Surface Malignancies

Computerized System for Staging Peritoneal Surface Malignancies Ann Surg Oncol (2016) 23:1454 1460 DOI 10.1245/s10434-015-4966-5 ORIGINAL ARTICLE GASTROINTESTINAL ONCOLOGY Computerized System for Staging Peritoneal Surface Malignancies Paolo Sammartino, MD, PhD, Daniele

More information

4th ESSO Advanced Course on the Management of Colorectal Liver Metastases

4th ESSO Advanced Course on the Management of Colorectal Liver Metastases 4th ESSO Advanced Course on the Management of Colorectal Liver Metastases 10-11 October 2016 BORDEAUX (FR) 4 th ESSO Advanced Course on the Management of Colorectal Liver Metastases Chairs Serge Evrard,

More information

LUMINAL IMAGING GROUP. Department of Radiology, Mayo Clinic, Rochester, MN 2. Department of Radiology, Mayo Clinic, Scottsdale, AZ 3

LUMINAL IMAGING GROUP. Department of Radiology, Mayo Clinic, Rochester, MN 2. Department of Radiology, Mayo Clinic, Scottsdale, AZ 3 HIPEC and Peritoneal Carcinomatosis: Evolving Role of Imaging in Defining Treatment David J. Bartlett, M.D. 1 Paul G. Thacker, Jr., MD, M.H.A. 1 Shannon P. Sheedy, M.D. 1 Christine O. Menias, M.D. 2 Travis

More information

Current standard in treatment of peritoneal carcinomotisis. Data behind the HIPEC trials

Current standard in treatment of peritoneal carcinomotisis. Data behind the HIPEC trials Current standard in treatment of peritoneal carcinomotisis Data behind the HIPEC trials Overview Peritoneal carcinomatosis STANDARD treatment HIPEC Results of treatment Counter side of treatment Peritoneal

More information

Cytoreduction and HIPEC for peritoneal carcinomatosis of pancreatic cancer

Cytoreduction and HIPEC for peritoneal carcinomatosis of pancreatic cancer JBUON 2018; 23(2): 482-487 ISSN: 1107-0625, online ISSN: 2241-6293 www.jbuon.com E-mail: editorial_office@jbuon.com ORIGINAL ARTICLE Cytoreduction and HIPEC for peritoneal carcinomatosis of pancreatic

More information

Clinical Study Adjuvant Perioperative Intraperitoneal Chemotherapy in Locally Advanced Colorectal Carcinoma: Preliminary Results

Clinical Study Adjuvant Perioperative Intraperitoneal Chemotherapy in Locally Advanced Colorectal Carcinoma: Preliminary Results International Scholarly Research Network ISRN Surgery Volume 2011, Article ID 529876, 6 pages doi:10.5402/2011/529876 Clinical Study Adjuvant Perioperative Intraperitoneal Chemotherapy in Locally Advanced

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE INTERVENTIONAL PROCEDURES PROGRAMME Interventional procedure overview of cytoreduction surgery followed by hyperthermic intraoperative peritoneal chemotherapy

More information

Short bowel syndrome after cytoreductive surgery and HIPEC: nutritional considerations

Short bowel syndrome after cytoreductive surgery and HIPEC: nutritional considerations JBUON 2014; 19(2): 549-553 ISSN: 1107-0625, online ISSN: 2241-6293 www.jbuon.com E-mail: editorial_office@jbuon.com ORIGINAL ARTICLE Short bowel syndrome after cytoreductive surgery and HIPEC: nutritional

More information

Treatment-related post-operative mortality after cytoreductive surgery and perioperative intraperitoneal chemotherapy

Treatment-related post-operative mortality after cytoreductive surgery and perioperative intraperitoneal chemotherapy Journal of Peritoneum (and other serosal surfaces) 2017; volume 2:65 Treatment-related post-operative mortality after cytoreductive surgery and perioperative intraperitoneal chemotherapy Boyoung Kim, 1

More information